As filed with the Securities and Exchange Commission on May 21, 2019
Registration No. 333-______
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
Cellcom Israel Ltd.
(Exact Name of Registrant as Specified in its Charter)
|
Israel
|
4812
|
Not applicable
|
|
(State or other jurisdiction of
incorporation or organization)
|
(Primary Standard Industrial
Classification No.)
|
(I.R.S. Employer
Identification No.)
|
|
|
10 Hagavish Street
Netanya, Israel 4250708
(972) 52-999-0052
(Address, including zip code, and telephone
number, including area code, of Registrant’s principal executive offices)
|
|
|
|
|
|
|
Cellcom Israel, Ltd. 2015 Share Incentive Plan
(Full title of the Plan)
|
|
|
C T CORPORATION SYSTEM
28 Liberty Street
New York, New York 10005
(212) 590-9070
|
|
|
|
|
|
|
|
(Name and address, including zip code, and
telephone number, including area code, of agent for service)
|
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b‑2 of the Securities Exchange Act of 1934, as amended.
|
|
Large accelerated filer ☐
Non-accelerated filer ☐
(Do not check if a smaller reporting company)
|
Accelerated filer ☒
Smaller reporting company ☐
Emerging growth company ☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
CALCULATION OF REGISTRATION FEE
|
Title of Each Class of Securities to be Registered
|
|
Amount To Be
Registered
(1)
|
|
|
Proposed
Maximum
Offering Price
Per Share
|
|
|
Proposed
Maximum
Aggregate
Offering Price
|
|
|
Amount of
Registration
Fee
(4)
|
|
|
Ordinary Shares of Cellcom Israel Ltd. (par value NIS 0.01) (“Ordinary Shares”)
|
|
|
7,288,673
|
|
|
$
|
4.575
|
(2)
|
|
$
|
33,345,678.98
|
|
|
$
|
4,041.50
|
|
|
|
|
|
379,101
|
|
|
$
|
4.389
|
(3)
|
|
$
|
1,663,874.29
|
|
|
$
|
201.66
|
|
|
Total:
|
|
|
7,667,774
|
|
|
|
-
|
|
|
$
|
35,009,553.27
|
|
|
$
|
4,243.16
|
|
|
(1)
|
Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) shall also cover any additional Ordinary Shares which become issuable under the Cellcom Israel, Ltd. 2015 Share Incentive Plan, as amended (the “Plan”), by reason of any share dividend, share split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding ordinary shares of Cellcom Israel Ltd. (the “Company” or the “Registrant”) as a result of share splits, share dividends and antidilution provisions.
|
|
(2)
|
Estimated pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, solely for the purpose of computing the registration fee, based on the average of the high and low prices reported for an Ordinary Share on the New York Stock Exchange on May 16, 2019.
|
|
(3)
|
Estimated pursuant to Rule 457(h) under the Securities Act based on the exercise price of the Ordinary Shares underlying option award grants.
|
|
(4)
|
Rounded up to the nearest cent.
|
EXPLANATORY NOTE
This Registration Statement has been prepared and filed pursuant to and in accordance with the requirements of General Instruction E to Form S-8 for the purpose of registering an additional 7,667,774 Ordinary Shares that are issuable at any time or from time to time under the Plan. Pursuant to General Instruction E, the contents of the Registration Statement on Form S-8 filed for the Plan with the Securities and Exchange Commission (the “Commission”) on August 13, 2015 (Registration No. 333-206338), including the documents incorporated by reference therein, are incorporated by reference into this Registration Statement, except as supplemented by the information set forth below.
Item 8. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, the City of Netanya, State of Israel, on the 21st day of May, 2019.
|
|
CELLCOM ISRAEL LTD.
|
|
|
|
|
|
By:
|
/s/ Nir Sztern
|
|
|
|
Name:
Nir Sztern
|
|
|
|
Title:
President and Chief Executive Officer
|
|
|
CELLCOM ISRAEL LTD.
|
|
|
|
|
|
By:
|
/s/ Shlomi Fruhling
|
|
|
|
Name:
Shlomi Fruhling
|
|
|
|
Title:
Chief Financial Officer
|
Know all persons by these presents, that each person whose signature appears below, constitutes and appoints each of Shlomi Fruhling and Liat Menahemi Stadler as his or her true and lawful attorney‑in‑fact and agent, upon the action of such appointee, with full power of substitution and resubstitution, to do any and all acts and things and execute, in the name of the undersigned, any and all instruments which each of said attorneys‑in‑fact and agents may deem necessary or advisable in order to enable Cellcom Israel Ltd. to comply with the Securities Act of 1933, as amended (the “Securities Act”), and any requirements of the Securities and Exchange Commission (the “Commission”) in respect thereof, in connection with the filing with the Commission of this Registration Statement under the Securities Act, including specifically but without limitation, power and authority to sign the name of the undersigned to such Registration Statement, and any amendments to such Registration Statement (including post-effective amendments), and to file the same with all exhibits thereto and other documents in connection therewith, with the Commission, to sign any and all applications, registration statements, notices or other documents necessary or advisable to comply with applicable state securities laws, and to file the same, together with other documents in connection therewith with the appropriate state securities authorities, granting unto each of said attorneys-in-fact and agents full power and authority to do and to perform each and every act and thing requisite or necessary to be done in and about the premises, as fully and to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that each of said attorneys‑in‑fact and agents may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed this 21st day of May, 2019 by the following persons in the following capacities.
|
Signature
|
Title
|
Date
|
|
|
|
|
|
/s/ Nir Sztern
|
President and Chief Executive Officer
(Principal Executive Officer)
|
05/21/2019
|
|
Nir Sztern
|
|
|
|
|
|
|
|
/s/ Shlomi Fruhling
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
05/21/2019
|
|
Shlomi Fruhling
|
|
|
|
|
|
|
|
/s/ Ami Erel
|
Chairman of the Board and Director
|
05/21/2019
|
|
Ami Erel
|
|
|
|
|
|
|
|
/s/ Mauricio Wior
|
Vice Chairman of the Board and Director
|
05/21/2019
|
|
Mauricio Wior
|
|
|
|
|
|
|
|
/s/ Sholem Lapidot
|
Director
|
05/21/2019
|
|
Sholem Lapidot
|
|
|
|
|
|
|
|
/s/ Ephraim Kunda
|
Director
|
05/21/2019
|
|
Ephraim Kunda
|
|
|
|
|
|
|
|
/s/ Gustavo Traiber
|
Director
|
05/21/2019
|
|
Gustavo Traiber
|
|
|
|
|
|
|
|
/s/ Varda Liberman
|
Director
|
05/21/2019
|
|
Varda Liberman
|
|
|
|
/s/ Shmuel Hauser
|
Director
|
|
|
Shmuel Hauser
|
|
|
|
|
|
|
|
|
Puglisi & Associates
|
|
|
|
|
|
By:
|
/s/ Gregory F. Lavelle
|
|
|
Name:
Gregory F. Lavelle
|
|
|
Title:
Managing Director
|
|
|
Authorized Representative in the United States
|
|
|
|
|
|
Date: May 21, 2019
|
Cellcom Israel (NYSE:CEL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cellcom Israel (NYSE:CEL)
Historical Stock Chart
From Apr 2023 to Apr 2024
